Legal corpus: the complete U.S. Code (59,740 sections, all 53 titles)

Ingested titles 12–51 and 54 from OLRC USLM XML @119-100 (the whole Code
now, uniform edition; Title 53 is reserved/empty). LegalText 11,221 ->
59,740; repo total 105,704 records. Deterministic (byte-identical rerun,
verified on Title 42's 8,356 sections); make check green. make
legal-us-code default now covers every title.

Co-Authored-By: Claude Opus 4.8 <noreply@anthropic.com>

legal/us/code/title-21/chapter-9/section-360a.md

@@ -0,0 +1,43 @@
+---
+type: "LegalText"
+title: "21 U.S.C. § 360a"
+description: "Clinical trial guidance for antibiotic drugs"
+jurisdiction: "us"
+corpus: "united_states_code"
+kind: "code_section"
+title_number: 21
+title_name: "FOOD AND DRUGS"
+chapter_number: "9"
+chapter_name: "FEDERAL FOOD, DRUG, AND COSMETIC ACT"
+section: "360a"
+citation: "21 U.S.C. § 360a"
+status: "current"
+release_point: "119-100"
+release_date: "2026-06-26"
+source: "official"
+source_url: "https://uscode.house.gov/download/releasepoints/us/pl/119/100/xml_usc21@119-100.zip"
+source_identifier: "/us/usc/t21/s360a"
+source_file: "data/legal/raw/us/code/title-21/usc21.xml"
+source_hash: "a7c2b71876fc914bdddb9d8ea97f1994bd115f6089fcee560a76bf1f7841ad38"
+raw_snapshot_hash: "3dbd7a61c8616baefb8459bd8dac3b93242106deb416308c8d4dd5a9143176d1"
+text_hash: "e5a426b40bb338203c7b2dda3cd5f446eecbc125cb8621ec45ba4ddc13f34f3a"
+retrieved_at: "2026-07-04"
+confidence: "official"
+tags: ["legal", "us-code"]
+---
+
+# 21 U.S.C. § 360a - Clinical trial guidance for antibiotic drugs
+
+## Text
+
+(a) In general Not later than 1 year after September 27, 2007, the Secretary shall issue guidance for the conduct of clinical trials with respect to antibiotic drugs, including antimicrobials to treat acute bacterial sinusitis, acute bacterial otitis media, and acute bacterial exacerbation of chronic bronchitis. Such guidance shall indicate the appropriate models and valid surrogate markers.
+
+(b) Review Not later than 5 years after September 27, 2007, the Secretary shall review and update the guidance described under subsection (a) to reflect developments in scientific and medical information and technology.
+
+(June 25, 1938, ch. 675, § 511, as added Pub. L. 110–85, title IX, § 911, Sept. 27, 2007, 121 Stat. 951.)
+
+## Notes
+
+Editorial Notes
+
+Prior ProvisionsA prior section 360a, act June 25, 1938, ch. 675, § 511, as added July 15, 1965, Pub. L. 89–74, § 3(b), 79 Stat. 227; amended Oct. 24, 1968, Pub. L. 90–639, § 2(a), 82 Stat. 1361, regulated the manufacture, compounding, and processing of depressant and stimulant drugs and their sale, delivery, disposal, possession, and recordkeeping activities connected therewith, prior to repeal by Pub. L. 91–513, title II, §§ 701(a), 704, Oct. 27, 1970, 84 Stat. 1281, 1284, effective on the first day of the seventh calendar month that began after Oct. 26, 1970.